OTC Stockz
No Result
View All Result
Sunday, March 26, 2023
  • Login
  • Home
  • OTC Stocks
  • Micro Caps
  • Stocks
  • Cryptocurrency
  • NFTs
  • Education
  • Home
  • OTC Stocks
  • Micro Caps
  • Stocks
  • Cryptocurrency
  • NFTs
  • Education
OTC Stockz
No Result
View All Result
Home Micro Caps

Bill Gates’ quiet biotech investment portfolio has made a new investment following his massive investment in Berkshire to purchase Microsoft.- LumiraDx (NASDAQ:LMDX)

by OTC Stockz
November 18, 2022
in Micro Caps
Reading Time: 2 mins read
0 0
A A
0
Bill Gates’ quiet biotech investment portfolio has made a new investment following his massive investment in Berkshire to purchase Microsoft.-  LumiraDx (NASDAQ:LMDX)
Share on FacebookShare on Twitter

  • More than 14.2 million shares in LumiraDx are purchased by Bill Gates, making it his fourth-largest holding.
  • During the third quarter, Gates reduces his holding in Atreca by more than 10,000 shares.

The Bill & Melinda Gates Foundation and the Bill & Melinda Gates Foundation Trust are two of Bill Gates’ investment portfolios. For the purposes of this article, we will examine the Bill & Melinda Gates Foundation, which invests a significant amount of money in stocks of companies engaged in biotechnology and the healthcare industry.

This fund has fewer holdings than the Bill & Melinda Gates Foundation Trust, with only ten holdings, and four of those holdings account for more than two-thirds of the portfolio. Additionally, investing in biotechnology stocks carries a high risk of loss if the product fails to live up to expectations or the market rejects it.

This could be the rationale for Gates’ decision to separate his riskier biotech holdings from his more conservative portfolio (the trust), which holds stocks like Microsoft Corporation and Berkshire Hathaway Inc. Unexpectedly, Gates reduced his ownership of Berkshire Hathaway and increased his stock purchases in Microsoft, making the latter his largest holding.

Table of Contents

  • What Was Purchased?
  • What Was Traded?
  • What Are The Top Three Positions?

What Was Purchased?

Gates only acquired one stock in this portfolio, LumiraDx Ltd. LMDX, which accounted for 12% of the portfolio and is now his fourth-most-owned position.

A wide range of tests can be supported by the diagnostic platform that LumiraDx creates and sells at the point of care, with performance comparable to that of a lab.

What Was Traded?

During the third quarter, Gates reduced his holdings in Atreca Inc. BCEL by more than 10,000 shares. The biopharmaceutical business Atreca finds and creates innovative antibody-based immunotherapeutic to treat a variety of solid tumor types using its unique platform.

What Are The Top Three Positions?

All three of Gates’ most concentrated holdings are biotechnology firms with an emphasis on the treatment and prevention of infectious diseases.

During the first quarter of 2022, Gates bought more than 880,000 shares in Vir Biotechnology Inc. VIR, and he hasn’t bought any more since. Vir Biotechnology Inc currently has a 24% ownership position.

During the first quarter of 2021, Gates initiated a holding in Immunocore Holdings PLC – ADR IMCR, which has stayed constant ever since. Currently, Immunocore Holdings accounts for 21% of the portfolio’s value.

In the third quarter of 2021, Gates sold at least 890,000 shares of BioNTech SE – ADR BNTX, which was the top position in the second quarter of 2021 and represented 36% of the fund at that time. The third-most-owned investment by Gates today, accounting for 16% of the portfolio, is BioNTech.

Photo: Shutterstock

Source link

How useful was this post?

Click on a star to rate it!

Average rating 0 / 5. Vote count: 0

No votes so far! Be the first to rate this post.

As you found this post useful...

Follow us on social media!

No Result
View All Result
  • Trending
  • Comments
  • Latest
Over the counter stocks (OTC Stock)

The role of market makers in over the counter stocks (OTC Stocks)

March 6, 2023
5 Common Mistakes to Avoid When Investing in Over the Counter (OTC) Stocks

5 Common Mistakes to Avoid When Investing in Over the Counter (OTC) Stocks

February 27, 2023
Why Are Stocks Down Today?

The Future of OTC Stocks: Navigating the Changing Landscape of Over-the-Counter Investments

February 13, 2023
Over the counter stocks (OTC Stock)

The Benefits of Investing in Over-The-Counter (OTC) Stocks

February 10, 2023
Over the counter stocks (OTC Stock)

Breaking Down the World of Over-the-Counter Stocks (OTC Stock): A Comprehensive Guide

February 10, 2023
In the penny stock market, Xcelerate, Inc. (OTC: XCRT) is emerging as a top Healthcare Services stock to watch in 2022. 

Fabian Urquijo Joins the Advisory Board of Xcelerate, Inc. (OTCMKT: XCRT)

February 2, 2023
OTC Markets Group Welcomes M.O.B.A. Network to OTCQX

Drive Shack Inc. Joins the OTCQX Best Market

January 31, 2023
New York Considers Bill to Establish Cryptocurrency as a Form of Payment for State Agencies

New York Considers Bill to Establish Cryptocurrency as a Form of Payment for State Agencies

January 30, 2023
OTC Stockz

Get the latest news and follow the coverage of OTC Stocks, Micro Caps, Cryptocurrency, NFTs and more from the top trusted sources.

CATEGORIES

  • Cryptocurrency
  • Micro Caps
  • NFTs
  • OTC Stocks
  • Stock Market
  • Stock Market Education
  • Trending
  • Writers Analysis

LATEST UPDATES

  • The role of market makers in over the counter stocks (OTC Stocks)
  • 5 Common Mistakes to Avoid When Investing in Over the Counter (OTC) Stocks
  • Home
  • Disclaimer
  • Privacy Policy
  • DMCA
  • Cookie Privacy Policy
  • Terms and Conditions
  • Contact us

Copyright © 2022 OTC Stockz.
OTC Stockz is not responsible for the content of external sites.

No Result
View All Result
  • Home
  • OTC Stocks
  • Micro Caps
  • Stocks
  • Cryptocurrency
  • NFTs
  • Education

Copyright © 2022 OTC Stockz.
OTC Stockz is not responsible for the content of external sites.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
Verified by MonsterInsights